Pubblicazioni

Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia

2020 - PEDIATRIC BLOOD & CANCER

Shah, N. N.; Bhojwani, D.; August, K.; Baruchel, A.; Bertrand, Y.; Boklan, J.; Dalla-Pozza, L.; Dennis, R.; Hijiya, N.; Locatelli, F.; Martin, P. L.; Mechinaud, F.; Moppett, J.; Rheingold, S. R.; Schmitt, C.; Trippett, T. M.; Liang, M.; Balic, K.; Li, X.; Vainshtein, I.; Yao, N. S.; Pastan, I.; Wayne, A. S.

Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

2019 - PEDIATRIC BLOOD & CANCER

Doz, F.; Locatelli, F.; Baruchel, A.; Blin, N.; De Moerloose, B.; Frappaz, D.; Dworzak, M.; Fischer, M.; Stary, J.; Fuertig, R.; Riemann, K.; Taube, T.; Reinhardt, D.

New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation

2015 - PEDIATRIC BLOOD & CANCER

Gaziev, J.; Isgro, A.; Mozzi, A. F.; Petain, A.; Nguyen, L.; Ialongo, C.; Dinallo, V.; Sodani, P.; Marziali, M.; Andreani, M.; Testi, M.; Paciaroni, K.; Gallucci, C.; De Angelis, G.; Alfieri, C.; Ribersani, M.; Lucarelli, G.